Inactive Instrument

World Medtronic, Inc. Share Price Monde

Equities

US5850551061

Medical Equipment, Supplies & Distribution

End-of-day quote Monde
- EUR - Intraday chart for Medtronic, Inc.

Financials

Sales 2024 * 32.24B 29.79B 2,538B Sales 2025 * 33.57B 31.02B 2,642B Capitalization 113B 104B 8,903B
Net income 2024 * 4.56B 4.21B 359B Net income 2025 * 5.24B 4.85B 413B EV / Sales 2024 * 4.2 x
Net Debt 2024 * 22.21B 20.52B 1,748B Net Debt 2025 * 21.12B 19.51B 1,662B EV / Sales 2025 * 4 x
P/E ratio 2024 *
24.3 x
P/E ratio 2025 *
21 x
Employees -
Yield 2024 *
3.23%
Yield 2025 *
3.4%
Free-Float 99.78%
More Fundamentals * Assessed data

Latest transcript on Medtronic, Inc.

Managers TitleAgeSince
Chief Executive Officer 54 25/01/15
Director of Finance/CFO 58 31/05/16
Chief Operating Officer 63 31/03/21
Members of the board TitleAgeSince
Director/Board Member 62 31/12/12
Director/Board Member 70 31/12/06
Director/Board Member 68 31/12/14
More insiders
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company